Group A | Group B | p value | Odds ratio | |
---|---|---|---|---|
N = 82 | N = 168 | (IC at 95%) | ||
Vaginal exposure of sacrocolpopexy mesh | 3 (3.7%) | 2 (1.2%) | 0.33 | 3.13 (0.35–38) |
Vaginal exposure of TVT-O® mesh | – | 2 on 41 patients | ||
Prolapse (relapse or de novo) | 0 | 3 (1.7%) | 0.55 | NA |
Stress urinary incontinence | 3 (3.7%) | 7 (4.2%) | 1 | 0.87 (0.14–3.96) |
among which a patient with TVT-O® | – | 1 | ||
Menorrhagias of remaining uterus | 0 | 1 | ||
Total of re-interventions | 6 (7%) | 15 (9%) | 0.67 | 0.81 (0.27–2.33) |